IPO Trending
ALIVUSEQ / NSE, BSEListed
Glenmark Life Sciences

Incorporated in 2011, Glenmark Life Sciences is a leading manufacturer of active pharmaceutical ingredients (APIs), developing and supplying high-quality products used in treatments for cardiovascular, central nervous system, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. The company serves customers in India and exports its products to several international markets including Europe, North America, Latin America, and Japan. It operates four manufacturing facilities located at Ankleshwar and Dahej in Gujarat, and Mohol and Kurkumbh in Maharashtra, with a total annual installed capacity of 725.8 KL as of December 31, 2020.

₹695 - ₹720Open
Listed Price₹750.00
Listing Gain+4.17%

IPO Schedule & Timeline

Bookbuilding IPO
Open27 Jul 2021
Close29 Jul 2021
Allotment03 Aug 2021
Listing06 Aug 2021

Quota Reservation & Application Lots

Quota Reservation (% Shares)

QIB1,05,11,110 shares
50%
Anchor63,06,660 shares
30%
Nii (hni)31,53,334 shares
15%
Retail73,57,778 shares
35%

Minimum Application Lots

Retail1 Lot (20 shares)
₹14,400
sHNI13 Lots (280 shares)
₹2,01,600
bHNI70 Lots (1,400 shares)
₹10,08,000

Company Promoters

Glenmark Pharmaceuticals Limited

Company Background

Incorporated in 2011, Glenmark Life Sciences is a leading manufacturer of active pharmaceutical ingredients (APIs), developing and supplying high-quality products used in treatments for cardiovascular, central nervous system, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. The company serves customers in I...

Financial Performance

Figures in ₹ Crores
Metric Breakdown

Revenue

Latest (Mar-21)₹18859.76 Cr
Growth+112.7%
Revenue Trend (₹ in Crores)
0.07.2k14.5k21.7kMar-19Mar-20Mar-21
PeriodRev (Cr)PAT (Cr)AssetsDebt
Mar-2118,859.763,515.8119,970.750
Mar-2015,493.033,130.9817,256.040
Mar-198,868.651,955.9214,753.950

Broker & Analyst Reviews

Review Not Available

Institutional broker reviews and analyst reports have not been released for this issue yet. Reviews are typically published 2 to 3 days prior to the issue opening date.

IPO Allotment & Registrar Status

Official Registrar: Kfin Technologies Limited

Allotment Finalized
Allotment Date
03 Aug 2021
Official Status
Out / Finalized
Registrar
Kfin Technologies Limited
Listing Date
06 Aug 2021

Official Allotment Verification Links

Official Registrar Portal
Kfin Technologies Limited

Direct allotment verification on the official registrar portal appointed for Glenmark Life Sciences. Check with PAN or Application No.

Check on Registrar Portal
Stock Exchange Portal
BSE India Investor Portal

Official Bombay Stock Exchange investor verification channel using Issue Name and PAN Number.

Check on BSE India

Allotment Schedule & Milestones

IST
1. Allotment Finalization03 Aug 2021Basis of allotment declared
2. Refund Initiation1 day post allotmentUPI / ASBA mandate unblocked
3. Demat CreditPrior to listingShares credited to CDSL/NSDL
4. Listing Date06 Aug 2021Trading commences on exchange

How to Check Glenmark Life Sciences Allotment Online

1Open Portal

Click on the official registrar link or BSE portal button above.

2Select Company

Select Glenmark Life Sciences from the issue drop-down list.

3Enter Details

Select PAN, Application No., or DP Client ID and type your details.

4View Allocation

Click Submit to check your allotted share count and status.

Prospectus & Official Filings

Allotment FAQs & Help

About Glenmark Life Sciences IPO

Complete issue overview for Glenmark Life Sciences (ALIVUS) IPO. The issue features an equity share price band of ₹695 – ₹720 per share with a minimum retail lot size of 20 Shares (minimum application amount of ₹14,400). Explore live market tracking on our GMP Tracker, compare against All IPO GMP Today, or view category bidding on the Subscription Page. Verify official allotment via IPO Registrars or review participating investment bankers in our Lead Managers Directory.

Frequently Asked Questions